countries. Pregnancies affected by FGR, frequently concur with complications and high risk
of neonatal morbidity and mortality. To date, no approved treatment is available for pregnant
women affected with FGR. The objective of this study was to investigate the contribution of
galectin-3 (gal-3), a β-galactoside binding protein involved in pregnancy, placental function
and fetal growth. We demonstrated that lack of gal-3 during mouse pregnancy leads to …